A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group (Q33370628)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q67015887)
(Q91544711)
(Q88386694)
(P304) 1750-1759
(P407) (Q1860)
(P433) 6
(P478) 12
(P577) Wednesday, March 1, 2006
(P921) (Q5452194)
(Q938205)
(P1433) (Q332253)
(P1476) "A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group" (language: en)
(P2093) Kaci L Osenga
Jacquelyn A Hank
Mark R Albertini
Jacek Gan
Adam G Sternberg
Jens Eickhoff
Clare Twist
Mark Krailo
Peter C Adamson
Ralph A Reisfeld
Stephen D Gillies
Paul M Sondel
Children's Oncology Group
(P2860) (Q33363235)
(Q40532794)
(Q35136013)
(Q35112891)
(Q34253585)
(Q33997679)
(Q41146152)
(Q46888249)
(Q40648026)
(Q42435560)
(Q37362175)
(Q41055870)
(Q41500257)
(Q40781897)
(Q42820571)
(Q44888410)
(Q41238346)
(Q47786985)
(Q44593124)
(Q49172758)
(Q48655040)
(Q74213475)
(Q68814698)
(Q73300396)
(Q84105852)
(Q70341820)
(Q68104450)
(Q77554668)
other details
description scientific article

External Links